Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1957 1
1962 1
1963 1
1964 1
1965 1
1968 4
1969 3
1971 3
1972 5
1973 3
1974 2
1975 3
1976 2
1977 4
1978 2
1979 8
1980 7
1981 8
1982 13
1983 6
1984 10
1985 12
1986 4
1987 13
1988 8
1989 20
1990 23
1991 18
1992 23
1993 30
1994 20
1995 35
1996 20
1997 33
1998 39
1999 24
2000 28
2001 27
2002 46
2003 63
2004 58
2005 63
2006 76
2007 96
2008 115
2009 119
2010 134
2011 166
2012 215
2013 221
2014 229
2015 256
2016 252
2017 243
2018 296
2019 302
2020 396
2021 413
2022 159
Text availability
Article attribute
Article type
Publication date

Search Results

3,845 results
Results by year
Filters applied: . Clear all
Page 1
Microbial exposure during early human development primes fetal immune cells.
Mishra A, Lai GC, Yao LJ, Aung TT, Shental N, Rotter-Maskowitz A, Shepherdson E, Singh GSN, Pai R, Shanti A, Wong RMM, Lee A, Khyriem C, Dutertre CA, Chakarov S, Srinivasan KG, Shadan NB, Zhang XM, Khalilnezhad S, Cottier F, Tan ASM, Low G, Chen P, Fan Y, Hor PX, Lee AKM, Choolani M, Vermijlen D, Sharma A, Fuks G, Straussman R, Pavelka N, Malleret B, McGovern N, Albani S, Chan JKY, Ginhoux F. Mishra A, et al. Among authors: tan asm. Cell. 2021 Jun 24;184(13):3394-3409.e20. doi: 10.1016/j.cell.2021.04.039. Epub 2021 Jun 1. Cell. 2021. PMID: 34077752 Free PMC article.
Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.
Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK, Tay ST, Ho SWT, Tan ALK, Ishimoto T, Kim G, Shabbir A, Chen Q, Zhang B, Xu S, Lam KP, Lum HYJ, Teh M, Yong WP, So JBY, Tan P. Kumar V, et al. Among authors: tan alk. Cancer Discov. 2022 Mar 1;12(3):670-691. doi: 10.1158/2159-8290.CD-21-0683. Cancer Discov. 2022. PMID: 34642171
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors.
Tan AC, Bagley SJ, Wen PY, Lim M, Platten M, Colman H, Ashley DM, Wick W, Chang SM, Galanis E, Mansouri A, Khagi S, Mehta MP, Heimberger AB, Puduvalli VK, Reardon DA, Sahebjam S, Simes J, Antonia SJ, Berry D, Khasraw M. Tan AC, et al. J Immunother Cancer. 2021 Jul;9(7):e002459. doi: 10.1136/jitc-2021-002459. J Immunother Cancer. 2021. PMID: 34215688 Free PMC article. Review.
SARS-CoV-2-specific T cells in infection and vaccination.
Bertoletti A, Le Bert N, Qui M, Tan AT. Bertoletti A, et al. Among authors: tan at. Cell Mol Immunol. 2021 Oct;18(10):2307-2312. doi: 10.1038/s41423-021-00743-3. Epub 2021 Sep 1. Cell Mol Immunol. 2021. PMID: 34471260 Free PMC article. Review.
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
Le Bert N, Clapham HE, Tan AT, Chia WN, Tham CYL, Lim JM, Kunasegaran K, Tan LWL, Dutertre CA, Shankar N, Lim JME, Sun LJ, Zahari M, Tun ZM, Kumar V, Lim BL, Lim SH, Chia A, Tan YJ, Tambyah PA, Kalimuddin S, Lye D, Low JGH, Wang LF, Wan WY, Hsu LY, Bertoletti A, Tam CC. Le Bert N, et al. Among authors: tan at. J Exp Med. 2021 May 3;218(5):e20202617. doi: 10.1084/jem.20202617. J Exp Med. 2021. PMID: 33646265 Free PMC article. Clinical Trial.
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Tan AR, Im SA, Mattar A, Colomer R, Stroyakovskii D, Nowecki Z, De Laurentiis M, Pierga JY, Jung KH, Schem C, Hogea A, Badovinac Crnjevic T, Heeson S, Shivhare M, Kirschbrown WP, Restuccia E, Jackisch C; FeDeriCa study group. Tan AR, et al. Lancet Oncol. 2021 Jan;22(1):85-97. doi: 10.1016/S1470-2045(20)30536-2. Epub 2020 Dec 21. Lancet Oncol. 2021. PMID: 33357420 Clinical Trial.
3,845 results